HTA180 The Value-Generation-Value-Recognition Gap for Novel Gene Therapies in European HTA Systems Using X-Linked Retinitis Pigmentosa as a Case Study
Abstract
Authors
JM Lee J Hitch S Brassel J Petersen T Denee L Steuten